Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Ekelund U, Tarp J, Ding D, Sanchez-Lastra MA, Dalene KE, Anderssen SA, Steene-Johannessen J, Hansen BH, Morseth B, Hopstock LA, Sagelv E, Nordström P, Nordström A, Hagströmer M, Dohrn IM, Diaz KM, Hooker S, Howard VJ, Lee IM, Fagerland MW(2026) Deaths potentially averted by small changes in physical activity and sedentary time: an individual participant data meta-analysis of prospective cohort studies Lancet(in press) DOI 10.1016/S0140-6736(25)02219-6, PubMed 41544645
Holmen H, Fosse E(2026) "I Want to Spend My Time Living"-Experiences With a Digital Outpatient Service With a Mobile App for Tailored Care Among Adults With Long-Term Health Service Needs: Qualitative Study Using Thematic Analysis J Med Internet Res, 28, e79155 DOI 10.2196/79155, PubMed 41538795
Kazemi AA, Kristianslund EK, Sexton J, Fagerli KM, Provan SA, Olsen IC(2026) A Head-to-Head Comparison of TNF-α Inhibitors as the First Biologic Treatment of Rheumatoid Arthritis Rheumatology (Oxford)(in press) DOI 10.1093/rheumatology/keag007, PubMed 41533706